Search

Your search keyword '"Wallon, David"' showing total 634 results

Search Constraints

Start Over You searched for: Author "Wallon, David" Remove constraint Author: "Wallon, David"
634 results on '"Wallon, David"'

Search Results

2. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease

4. Phenotype and imaging features associated with APP duplications

5. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

6. Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease

8. Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening

10. Plasma lysosphingolipids in GRN-related diseases: Monitoring lysosomal dysfunction to track disease progression

11. Comparison of Pittsburgh compound B and florbetapir in cross‐sectional and longitudinal studies

12. Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

13. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

14. New insights into the genetic etiology of Alzheimer’s disease and related dementias

15. Prodromal characteristics of dementia with Lewy bodies: baseline results of the MEMENTO memory clinics nationwide cohort

18. A postzygotic de novo NCDN mutation identified in a sporadic FTLD patient results in neurochondrin haploinsufficiency and altered FUS granule dynamics

20. État des lieux en France du parcours de soin en centre mémoire des patients atteints d'une maladie d'Alzheimer débutante.

21. Primary brain calcification: an international study reporting novel variants and associated phenotypes.

22. Validity and Performance of Blood Biomarkers for Alzheimer Disease to Predict Dementia Risk in a Large Clinic-Based Cohort

24. Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

25. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.

26. Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers

27. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

28. Cerebral Amyloid Angiopathy-Related Inflammation and Biopsy-Positive Primary Angiitis of the CNS: A Comparative Study.

29. Amyloid-β peptide signature associated with cerebral amyloid angiopathy in familial Alzheimer's disease with APPdup and Down syndrome.

31. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

32. High diagnostic value of plasma Niemann-Pick type C biomarkers in adults with selected neurological and/or psychiatric disorders

33. Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease

35. Transferability of a European-derived Alzheimer’s Disease Genetic Risk Score across Multi-Ancestry Populations

36. Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers

37. Added value of 18F-florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study

38. Correction: Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain

39. Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease

40. Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers

41. Decrease in the cortex/striatum metabolic ratio on [18F]-FDG PET: a biomarker of autoimmune encephalitis

43. Associations among hypertension, dementia biomarkers, and cognition: The MEMENTO cohort.

45. Cerebrospinal Fluid Profile of Tau, Phosphorylated Tau, Aβ42, and Aβ40 in Probable Cerebral Amyloid Angiopathy

49. Telemedicine in French Memory Clinics During the COVID-19 Pandemic

50. Additional file 1 of Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes

Catalog

Books, media, physical & digital resources